About this trial
The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.
Eligibility criteria
Qualifiers
Age ≥18 years
Consents to participation in the study
Verified endometriosis (by laparoscopy or ultrasound).
Chronic endometriosis-related pain (> 3 months), available for TENS treatment
Disqualifiers
Patient with inability to understand and use written and spoken Swedish
Patient with pacemaker and/or ICD or other electronic implants
Patient with impaired sensation over the painful area
Malignant disease with an expected survival <12 months
Trial design
Treatments tested in this trial
- Transcutaneous electrical nerve stimulation (TENS)
- Conventional analgesic treatment
Treatment groups
Sponsors and collaborators
Göteborg University
Lead sponsor
Vastra Gotaland Region
Collaborator